Literature DB >> 9076589

Development and validation of a discriminative quality of life questionnaire for osteoporosis (the OPTQoL).

E Lydick1, S I Zimmerman, B Yawn, B Love, M Kleerekoper, P Ross, A Martin, R Holmes.   

Abstract

We report the development and validation of an osteoporosis-targeted quality of life questionnaire to measure the impact of the disease in the general population. From multiple focus groups with women with osteoporosis, healthy women at risk for osteoporosis, spouses and relatives of women with osteoporosis, and health care providers, we identified over 300 potential items related to the disease. A lengthy questionnaire incorporated these items and was administered to a second large study cohort of 222 women with clinical osteoporosis (history of fracture, significant height loss, and/or kyphosis); 101 women with known low bone mineral density levels that would categorize them as osteoporotic but who had not yet shown obvious physical manifestations of the disease; and 142 women with other conditions (such as arthritis, cancer, depression) expected to also have an impact on quality of life. Final items from among the original 300 were chosen for their demonstrated relationship with osteoporosis as measured by clinical manifestations and low bone density and with quality of life measured by a standard generic questionnaire, the SF-36. The final questionnaire contains 26 scored items in three domains-physical activity, adaptations, and fears- and six nonscored questions relating to osteoporotic changes and diagnosis. This instrument is unique among osteoporosis-targeted questionnaires in that it attempts to measure the total impact of the disease on quality of life within a population at a single point in time.

Entities:  

Mesh:

Year:  1997        PMID: 9076589     DOI: 10.1359/jbmr.1997.12.3.456

Source DB:  PubMed          Journal:  J Bone Miner Res        ISSN: 0884-0431            Impact factor:   6.741


  32 in total

1.  Both resistance and agility training reduce back pain and improve health-related quality of life in older women with low bone mass.

Authors:  Teresa Y L Liu-Ambrose; Karim M Khan; Janice J Eng; Stephen R Lord; Brian Lentle; Heather A McKay
Journal:  Osteoporos Int       Date:  2005-02-09       Impact factor: 4.507

2.  Issues in conducting cross-cultural research: implementation of an agreed international protocol [corrected] designed by the WHOQOL Group for the conduct of focus groups eliciting the quality of life of older adults.

Authors:  Graeme Hawthorne; Natasha Davidson; Kathryn Quinn; Farah McCrate; Ines Winkler; Ramona Lucas; Reinhold Kilian; Anita Molzahn
Journal:  Qual Life Res       Date:  2006-09-14       Impact factor: 4.147

Review 3.  Quality of life in sarcopenia and frailty.

Authors:  René Rizzoli; Jean-Yves Reginster; Jean-François Arnal; Ivan Bautmans; Charlotte Beaudart; Heike Bischoff-Ferrari; Emmanuel Biver; Steven Boonen; Maria-Luisa Brandi; Arkadi Chines; Cyrus Cooper; Sol Epstein; Roger A Fielding; Bret Goodpaster; John A Kanis; Jean-Marc Kaufman; Andrea Laslop; Vincenzo Malafarina; Leocadio Rodriguez Mañas; Bruce H Mitlak; Richard O Oreffo; Jean Petermans; Kieran Reid; Yves Rolland; Avan Aihie Sayer; Yannis Tsouderos; Marjolein Visser; Olivier Bruyère
Journal:  Calcif Tissue Int       Date:  2013-07-05       Impact factor: 4.333

4.  Nurse case-manager vs multifaceted intervention to improve quality of osteoporosis care after wrist fracture: randomized controlled pilot study.

Authors:  S R Majumdar; J A Johnson; D Bellerose; F A McAlister; A S Russell; D A Hanley; S Garg; D A Lier; W P Maksymowych; D W Morrish; B H Rowe
Journal:  Osteoporos Int       Date:  2010-04-01       Impact factor: 4.507

5.  Morphometric vertebral fractures of the lower thoracic and lumbar spine, physical function and quality of life in men.

Authors:  J A Pasco; M J Henry; S Korn; G C Nicholson; M A Kotowicz
Journal:  Osteoporos Int       Date:  2008-09-19       Impact factor: 4.507

6.  Adherence to osteoporosis therapy after an upper extremity fracture: a pre-specified substudy of the C-STOP randomized controlled trial.

Authors:  F A McAlister; C Ye; L A Beaupre; B H Rowe; J A Johnson; D Bellerose; I Hassan; S R Majumdar
Journal:  Osteoporos Int       Date:  2018-09-19       Impact factor: 4.507

7.  Critical impact of patient knowledge and bone density testing on starting osteoporosis treatment after fragility fracture: secondary analyses from two controlled trials.

Authors:  S R Majumdar; F A McAlister; J A Johnson; D L Weir; D Bellerose; D A Hanley; A S Russell; B H Rowe
Journal:  Osteoporos Int       Date:  2014-05-07       Impact factor: 4.507

Review 8.  The impact of fragility fracture on health-related quality of life : the importance of antifracture therapy.

Authors:  Ted Xenodemetropoulos; Shawn Davison; George Ioannidis; Jonathan D Adachi
Journal:  Drugs Aging       Date:  2004       Impact factor: 3.923

9.  Multifaceted intervention to improve diagnosis and treatment of osteoporosis in patients with recent wrist fracture: a randomized controlled trial.

Authors:  Sumit R Majumdar; Jeffrey A Johnson; Finlay A McAlister; Debbie Bellerose; Anthony S Russell; David A Hanley; Don W Morrish; Walter P Maksymowych; Brian H Rowe
Journal:  CMAJ       Date:  2008-02-26       Impact factor: 8.262

10.  Community-based randomised controlled trial evaluating falls and osteoporosis risk management strategies.

Authors:  P M Ciaschini; S E Straus; L R Dolovich; R A Goeree; K M Leung; C R Woods; G M Zimmerman; S R Majumdar; S Spadafora; L A Fera; H N Lee
Journal:  Trials       Date:  2008-11-04       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.